Detalhe da pesquisa
1.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Br J Clin Pharmacol
; 90(1): 264-273, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602480
2.
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.
J Antimicrob Chemother
; 75(11): 3344-3348, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32791523
3.
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
J Antimicrob Chemother
; 78(3): 853-854, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683308
4.
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.
HIV Clin Trials
; 17(2): 63-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27077673
5.
A HPLC-DAD method to facilitate large-scale therapeutic drug monitoring of dalbavancin.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1222: 123694, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060815
6.
Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.
Cells
; 11(2)2022 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053324
7.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Antiviral Res
; 181: 104866, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659293
8.
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
Antimicrob Agents Chemother
; 53(9): 3650-6, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19528265
9.
Cefoxitin-based antibiotic therapy for extended-spectrum ß-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Int J Antimicrob Agents
; 51(6): 836-841, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378342
10.
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
J Antimicrob Chemother
; 67(11): 2779-81, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773742
11.
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study).
Antivir Ther
; 22(6): 461-469, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27583701
12.
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
PLoS One
; 11(10): e0164240, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798641
13.
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.
Medicine (Baltimore)
; 95(37): e4890, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27631261
14.
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
AIDS
; 30(13): 2085-90, 2016 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27149089
15.
Lopinavir/ritonavir combination and total/HDL cholesterol ratio.
J Infect
; 50(3): 229-35, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15780417
16.
In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils.
Clin Drug Investig
; 25(10): 643-50, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17532709
17.
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.
Int J STD AIDS
; 26(11): 831-4, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25332227
18.
PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results.
AIDS
; 16(17): 2311-5, 2002 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-12441803
19.
An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patients.
J Immunol Methods
; 295(1-2): 37-48, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15627609
20.
Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA.
J Immunol Methods
; 263(1-2): 1-9, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12009199